e-learning
resources
Madrid 2019
Monday, 30.09.2019
Eosinophils and FeNO in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
FENO Guided Therapy in Asthma: A Non-inferiority Study
T. Kulkarni (Kolkata, India), A. Mukherjee (Kolkata, India), B. Biswas (Kolkata, India), A. Ghosal (Kolkata, India), R. Dhar (Kolkata, India)
Source:
International Congress 2019 – Eosinophils and FeNO in airway diseases
Session:
Eosinophils and FeNO in airway diseases
Session type:
Oral Presentation
Number:
2153
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Kulkarni (Kolkata, India), A. Mukherjee (Kolkata, India), B. Biswas (Kolkata, India), A. Ghosal (Kolkata, India), R. Dhar (Kolkata, India). FENO Guided Therapy in Asthma: A Non-inferiority Study. 2153
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
e-Monitoring of Asthma Therapy to Improve Compliance in children (e-MATIC): a randomised controlled trial
Source: Eur Respir J 2016; 48: 758-767
Year: 2016
Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019
BREEZE: Open-label, Clinical Study to Evaluate the Safety and Tolerability of a Treprostinil Dry Powder Inhaler in Patients with Pulmonary Arterial Hypertension Currently Using Tyvaso
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2018
Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma.
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Curcumin Improves Therapy of Moderate Partially Controlled Asthma: Placebo-controlled, single blind study
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control
Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD
Year: 2020
Effects of MACVIA-ARIA Sentinel Network for Allergic Rhinitis (MASK-Air) Mobile Phone Application on Asthma Control in Patients with Asthma
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020
Interdisciplinary Pilot Project on Emphysema Quantification and Bronchial Wall Thickness assessment in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Guideline Adherence and Identifying Cost Effective Medication
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Co-Morbidities Are Serious Confounders of Asthma in Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
Exacerbations and Eosinophil Levels in ACCESS Cohort Participants Prescribed Inhaled Triple Therapy
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018
Barriers to Exercise in Difficult Asthma in the WATCH Cohort
Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases
Year: 2020
Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept